POSACONAZOLE
posaconazole 100 mg modified release tablet, 24
POSACONAZOLE (10460M)
10460M
Manner of administration:Oral
Restriction
Indication: Invasive aspergillosis
Restriction
Indication: Prophylaxis of invasive fungal infections including both yeasts and moulds
Restriction
Indication: Fungal infection
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 24 | # of repeats: 0 | DPMQ: $127.07 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||
|
|
|||||